# Efficacy and Safety of Qinbudan as an Adjunct Therapy for Retreatment Pulmonary Tuberculosis

> **NCT02313610** · PHASE2 · COMPLETED · sponsor: **Shanghai University of Traditional Chinese Medicine** · enrollment: 253 (actual)

## Conditions studied

- Pulmonary Tuberculosis

## Interventions

- **DRUG:** Qinbudan
- **DRUG:** Qinbudan Placebo

## Key facts

- **NCT ID:** NCT02313610
- **Lead sponsor:** Shanghai University of Traditional Chinese Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 253 (ACTUAL)
- **Last updated:** 2016-10-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02313610

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02313610, "Efficacy and Safety of Qinbudan as an Adjunct Therapy for Retreatment Pulmonary Tuberculosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02313610. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*